OraSure Technologies Interest Expense 2011-2026 | OSUR

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense OraSure Technologies

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-380 K	17.8 M	3.45 M	872 K	1.65 M	2.72 M	3.29 M	794 K	58 K	774 K	531 K	200 K	172 K	316 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
17.8 M	-380 K	2.31 M

Quarterly Interest Expense OraSure Technologies

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
154 K	-	-21 K	-	95 K	-43 K	271 K	-	2.61 M	1.47 M	2.67 M	-	3.26 M	1.71 M	168 K	-	100 K	448 K	-119 K	-	314 K	216 K	1.43 M	477 K	1.2 M	524 K	524 K	1.63 M	510 K	736 K	412 K	118 K	113 K	96 K	467 K	92 K	498 K	-340 K	-192 K	379 K	81 K	-95 K	409 K	287 K	268 K	-142 K	118 K	164 K	41 K	42 K	-47 K	26 K	22 K	74 K	75 K	-158 K	85.1 K	79.6 K	78.2 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.26 M	-340 K	441 K

Interest Expense of other stocks in the Medical instruments industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	149	-	-	$ 810 M	USA
Becton, Dickinson and Company BDX	613 M	$ 184.86	1.31 %	$ 53.2 B	USA
Baxter International BAX	290 M	$ 21.74	1.85 %	$ 11.2 B	USA
Ekso Bionics Holdings EKSO	-1 K	$ 11.29	-8.21 %	$ 228 M	USA
ICU Medical ICUI	93.3 M	$ 155.85	4.08 %	$ 3.84 B	USA
Alcon ALC	192 M	$ 82.21	-1.21 %	$ 40.4 B	Schweiz
AtriCure ATRC	683 K	$ 32.79	1.27 %	$ 1.57 B	USA
electroCore ECOR	6.3 M	$ 6.16	-0.16 %	$ 34 K	USA
Harvard Bioscience HBIO	-227 K	$ 0.58	-0.56 %	$ 24.6 M	USA
LeMaitre Vascular LMAT	205 K	$ 92.55	0.75 %	$ 2.08 B	USA
AngioDynamics ANGO	4.94 M	$ 11.22	0.13 %	$ 458 M	USA
InfuSystem Holdings INFU	1.4 M	$ 7.9	-	$ 163 M	USA
The Cooper Companies COO	-16.4 M	$ 84.11	0.51 %	$ 16.7 B	USA
Haemonetics Corporation HAE	-9.75 M	$ 61.61	1.55 %	$ 3.1 B	USA
iRhythm Technologies IRTC	5.44 M	$ 150.56	-5.24 %	$ 4.82 B	USA
Isoray ISR	2 K	-	0.03 %	$ 108 M	USA
Glaukos Corporation GKOS	13.6 M	$ 119.69	2.21 %	$ 5.8 B	USA
Repro Med Systems KRMD	561 K	$ 4.72	0.64 %	$ 215 M	USA
Masimo Corporation MASI	300 K	$ 175.38	0.03 %	$ 9.35 B	USA
Merit Medical Systems MMSI	-711 K	$ 82.25	0.5 %	$ 4.79 B	USA
Microbot Medical MBOT	2 K	$ 2.07	-3.95 %	$ 21.1 M	Israel
Nephros NEPH	2 K	$ 4.14	6.43 %	$ 43 M	USA
Milestone Scientific MLSS	60.3 K	$ 0.26	-2.04 %	$ 20.7 M	USA
DENTSPLY SIRONA XRAY	12 M	$ 12.63	0.88 %	$ 2.57 B	USA
Envista Holdings Corporation NVST	-2.3 M	$ 29.16	1.53 %	$ 4.9 B	USA
Pro-Dex PDEX	533 K	$ 39.55	1.41 %	$ 130 M	USA
Pulse Biosciences PLSE	-52 K	$ 21.98	-12.38 %	$ 1.48 B	USA
Predictive Oncology POAI	3	-	-	$ 31.1 M	USA
Stereotaxis STXS	1.1 M	$ 2.08	-0.24 %	$ 168 M	USA
Repligen Corporation RGEN	8.12 M	$ 136.76	-0.34 %	$ 7.62 M	USA
ResMed RMD	3.2 M	$ 258.04	0.68 %	$ 37.7 B	USA
BioLife Solutions BLFS	497 K	$ 23.17	-0.26 %	$ 1.07 B	USA
STERIS plc STE	8.4 M	$ 250.32	-0.34 %	$ 24.7 B	USA
Retractable Technologies RVP	227 K	$ 0.67	-3.48 %	$ 20.1 M	USA
STAAR Surgical Company STAA	815 K	$ 17.65	-1.29 %	$ 867 M	USA
Teleflex Incorporated TFX	57 M	$ 115.88	3.65 %	$ 5.43 B	USA
Utah Medical Products UTMD	256 K	$ 67.96	2.09 %	$ 247 M	USA
West Pharmaceutical Services WST	-1 M	$ 241.54	-0.94 %	$ 17.5 B	USA